Ameriprise’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-20,629
Closed -$210K 4031
2025
Q1
$210K Sell
20,629
-4,301
-17% -$43.9K ﹤0.01% 3742
2024
Q4
$348K Buy
24,930
+6,157
+33% +$85.9K ﹤0.01% 3636
2024
Q3
$366K Sell
18,773
-689
-4% -$13.4K ﹤0.01% 3574
2024
Q2
$362K Buy
19,462
+4,756
+32% +$88.5K ﹤0.01% 3540
2024
Q1
$206K Sell
14,706
-15,433
-51% -$216K ﹤0.01% 3683
2023
Q4
$255K Sell
30,139
-2,421
-7% -$20.5K ﹤0.01% 3655
2023
Q3
$291K Sell
32,560
-133
-0.4% -$1.19K ﹤0.01% 3592
2023
Q2
$282K Sell
32,693
-33,598
-51% -$290K ﹤0.01% 3625
2023
Q1
$699K Buy
66,291
+6,761
+11% +$71.3K ﹤0.01% 3300
2022
Q4
$2.02M Buy
59,530
+6,595
+12% +$223K ﹤0.01% 2805
2022
Q3
$2.54M Buy
52,935
+1,940
+4% +$93.1K ﹤0.01% 2674
2022
Q2
$2.91M Sell
50,995
-1,066
-2% -$60.8K ﹤0.01% 2633
2022
Q1
$4.21M Sell
52,061
-1,252
-2% -$101K ﹤0.01% 2533
2021
Q4
$10.8M Buy
53,313
+34,973
+191% +$7.09M ﹤0.01% 1928
2021
Q3
$4.94M Sell
18,340
-925
-5% -$249K ﹤0.01% 2393
2021
Q2
$4.96M Sell
19,265
-111,818
-85% -$28.8M ﹤0.01% 2463
2021
Q1
$39.3M Buy
131,083
+110,506
+537% +$33.2M 0.01% 887
2020
Q4
$5.25M Sell
20,577
-1,230
-6% -$314K ﹤0.01% 2238
2020
Q3
$5.43M Sell
21,807
-1,344
-6% -$334K ﹤0.01% 2011
2020
Q2
$8.04M Sell
23,151
-420
-2% -$146K ﹤0.01% 1695
2020
Q1
$6.31M Sell
23,571
-1,895
-7% -$507K ﹤0.01% 1738
2019
Q4
$8.25M Buy
25,466
+20,658
+430% +$6.69M ﹤0.01% 1903
2019
Q3
$1.32M Buy
4,808
+923
+24% +$252K ﹤0.01% 2891
2019
Q2
$2.07M Sell
3,885
-1,531
-28% -$817K ﹤0.01% 2731
2019
Q1
$2.73M Buy
5,416
+720
+15% +$363K ﹤0.01% 2589
2018
Q4
$2.32M Sell
4,696
-983
-17% -$485K ﹤0.01% 2588
2018
Q3
$5.19M Buy
5,679
+596
+12% +$545K ﹤0.01% 2316
2018
Q2
$3.66M Sell
5,083
-2,840
-36% -$2.04M ﹤0.01% 2448
2018
Q1
$12.6M Sell
7,923
-51,975
-87% -$82.9M 0.01% 1476
2017
Q4
$53.7M Sell
59,898
-3,094
-5% -$2.77M 0.02% 558
2017
Q3
$22.7M Sell
62,992
-504
-0.8% -$181K 0.01% 966
2017
Q2
$18.6M Buy
63,496
+5,300
+9% +$1.55M 0.01% 1076
2017
Q1
$20.5M Buy
58,196
+7,027
+14% +$2.47M 0.01% 1001
2016
Q4
$9.42M Buy
51,169
+5,803
+13% +$1.07M 0.01% 1579
2016
Q3
$11.7M Buy
45,366
+1,435
+3% +$370K 0.01% 1325
2016
Q2
$9.38M Buy
43,931
+1,695
+4% +$362K 0.01% 1442
2016
Q1
$8.71M Buy
42,236
+1,161
+3% +$239K 0.01% 1535
2015
Q4
$10.4M Sell
41,075
-421
-1% -$106K 0.01% 1419
2015
Q3
$6.82M Buy
41,496
+234
+0.6% +$38.5K ﹤0.01% 1765
2015
Q2
$7.74M Buy
41,262
+37,665
+1,047% +$7.07M ﹤0.01% 1803
2015
Q1
$593K Buy
3,597
+1,890
+111% +$312K ﹤0.01% 3132
2014
Q4
$397K Buy
1,707
+1,109
+185% +$258K ﹤0.01% 3209
2014
Q3
$109K Sell
598
-419
-41% -$76.4K ﹤0.01% 3639
2014
Q2
$195K Buy
1,017
+861
+552% +$165K ﹤0.01% 3334
2014
Q1
$29K Buy
156
+20
+15% +$3.72K ﹤0.01% 4027
2013
Q4
$23K Sell
136
-494
-78% -$83.5K ﹤0.01% 3999
2013
Q3
$98K Hold
630
﹤0.01% 3472
2013
Q2
$109K Buy
+630
New +$109K ﹤0.01% 3341